A Phase 2 Evaluation of TRC105 In Combination With Bevacizumab in Patients With Glioblastoma

Clinical trial NCT01564914 · COMPLETED

Trial details

NCT number: NCT01564914
Sponsor: Tracon Pharmaceuticals Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Glioblastoma Glioblastoma Multiforme

Start date: 2012-05-01
Primary completion: 2015-06-01
Enrollment: 22

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.